-+ 0.00%
-+ 0.00%
-+ 0.00%

Global Brain leads investment in cancer detection startup MiRNDa

PUBT·08/25/2026 01:03:45
Listen to the news
Global Brain leads investment in cancer detection startup MiRNDa
  • Global Brain led an equity investment in MiRNDa, a biotech startup developing early cancer detection using RNA modification analysis of blood samples.
  • Funding came via the TAKANAWA GATEWAY Global Co-Benefits Fund and the Meiji Yasuda Future Innovation Fund.
  • MiRNDa was founded in April 2025 based on technology discovered by Masamitsu Konno at Japan’s AIST.
  • Investment followed MiRNDa winning the TAKANAWA FUND Award at the GATEWAY Tech TAKANAWA 2026 PITCH in May.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Brain Corp published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.